Literature DB >> 25996059

Something old, something new: is praziquantel enough for schistosomiasis control?

W Evan Secor1, Susan P Montgomery.   

Abstract

Entities:  

Keywords:  mass drug administration; praziquantel; schistosomiasis

Mesh：

Substances：

Year:  2015        PMID： 25996059      PMCID： PMC4795816          DOI： 10.4155/fmc.15.9

Source DB:  PubMed          Journal:  Future Med Chem        ISSN： 1756-8919            Impact factor:   3.808


× No keyword cloud information.
  19 in total

1.  Schistosomiasis: number of people treated in 2011.

Authors: 
Journal:  Wkly Epidemiol Rec       Date:  2013-02-22

2.  Community health workers' experiences and perspectives on mass drug administration for schistosomiasis control in western Kenya: the SCORE Project.

Authors:  Martin O Omedo; Elizabeth J Matey; Alphonce Awiti; Michael Ogutu; Jane Alaii; Diana M S Karanja; Susan P Montgomery; W Evan Secor; Pauline N M Mwinzi
Journal:  Am J Trop Med Hyg       Date:  2012-10-22       Impact factor: 2.345

3.  Comparative efficacy of one versus two doses of praziquantel on cure rate of Schistosoma mansoni infection and re-infection in Mayuge District, Uganda.

Authors:  Edridah M Tukahebwa; Birgitte J Vennervald; Fred Nuwaha; Narcis B Kabatereine; Pascal Magnussen
Journal:  Trans R Soc Trop Med Hyg       Date:  2013-04-17       Impact factor: 2.184

4.  Genetic and molecular basis of drug resistance and species-specific drug action in schistosome parasites.

Authors:  Claudia L L Valentim; Donato Cioli; Frédéric D Chevalier; Xiaohang Cao; Alexander B Taylor; Stephen P Holloway; Livia Pica-Mattoccia; Alessandra Guidi; Annalisa Basso; Isheng J Tsai; Matthew Berriman; Claudia Carvalho-Queiroz; Marcio Almeida; Hector Aguilar; Doug E Frantz; P John Hart; Philip T LoVerde; Timothy J C Anderson
Journal:  Science       Date:  2013-11-21       Impact factor: 47.728

5.  Efficacy and safety of two closely spaced doses of praziquantel against Schistosoma haematobium and S. mansoni and re-infection patterns in school-aged children in Niger.

Authors:  Amadou Garba; Mariama S Lamine; Nouhou Barkiré; Ali Djibo; Boubacar Sofo; Anouk N Gouvras; Rabiou Labbo; Hannatou Sebangou; Joanne P Webster; Alan Fenwick; Jürg Utzinger
Journal:  Acta Trop       Date:  2012-08-23       Impact factor: 3.112

Review 6.  Time to set the agenda for schistosomiasis elimination.

Authors:  David Rollinson; Stefanie Knopp; Sarah Levitz; J Russell Stothard; Louis-Albert Tchuem Tchuenté; Amadou Garba; Khalfan A Mohammed; Nadine Schur; Bobbie Person; Daniel G Colley; Jürg Utzinger
Journal:  Acta Trop       Date:  2012-05-10       Impact factor: 3.112

7.  Can mass drug administration lead to the sustainable control of schistosomiasis?

Authors:  Allen G P Ross; Remigio M Olveda; Delia Chy; David U Olveda; Yuesheng Li; Donald A Harn; Darren J Gray; Donald P McManus; Veronica Tallo; Thao N P Chau; Gail M Williams
Journal:  J Infect Dis       Date:  2014-07-28       Impact factor: 5.226

Review 8.  The little we know about the pharmacokinetics and pharmacodynamics of praziquantel (racemate and R-enantiomer).

Authors:  Piero Olliaro; Petra Delgado-Romero; Jennifer Keiser
Journal:  J Antimicrob Chemother       Date:  2014-01-02       Impact factor: 5.790

Review 9.  Utility of repeated praziquantel dosing in the treatment of schistosomiasis in high-risk communities in Africa: a systematic review.

Authors:  Charles H King; Stephanie K Olbrych; Margaret Soon; Mendel E Singer; Jen Carter; Daniel G Colley
Journal:  PLoS Negl Trop Dis       Date:  2011-09-20

10.  Study and implementation of urogenital schistosomiasis elimination in Zanzibar (Unguja and Pemba islands) using an integrated multidisciplinary approach.

Authors:  Stefanie Knopp; Khalfan A Mohammed; Said M Ali; I Simba Khamis; Shaali M Ame; Marco Albonico; Anouk Gouvras; Alan Fenwick; Lorenzo Savioli; Daniel G Colley; Jürg Utzinger; Bobbie Person; David Rollinson
Journal:  BMC Public Health       Date:  2012-10-30       Impact factor: 3.295
View more
  15 in total

Review 1.  Susceptibility Testing of Medically Important Parasites.

Authors:  Abebe Genetu Bayih; Anjan Debnath; Edward Mitre; Christopher D Huston; Benoît Laleu; Didier Leroy; Benjamin Blasco; Brice Campo; Timothy N C Wells; Paul A Willis; Peter Sjö; Wesley C Van Voorhis; Dylan R Pillai
Journal:  Clin Microbiol Rev       Date:  2017-07       Impact factor: 26.132

2.  In vivo treatment with nitazoxanide induces anaerobic metabolism in experimental intraperitoneal cysticercosis.

Authors:  Joelma M Nasareth; Carolina M Fraga; Nayana F Lima; Guaraciara A Picanço; Tatiane L Costa; Ruy S Lino-Junior; Marina Clare Vinaud
Journal:  Parasitol Res       Date:  2017-09-15       Impact factor: 2.289

Review 3.  To Reduce the Global Burden of Human Schistosomiasis, Use 'Old Fashioned' Snail Control.

Authors:  Susanne H Sokolow; Chelsea L Wood; Isabel J Jones; Kevin D Lafferty; Armand M Kuris; Michael H Hsieh; Giulio A De Leo
Journal:  Trends Parasitol       Date:  2017-11-07

Review 4.  Development of a schistosomiasis vaccine.

Authors:  Adebayo J Molehin; Juan U Rojo; Sabrina Z Siddiqui; Sean A Gray; Darrick Carter; Afzal A Siddiqui
Journal:  Expert Rev Vaccines       Date:  2016-01-13       Impact factor: 5.217

Review 5.  Mechanically produced schistosomula as a higher-throughput tools for phenotypic pre-screening in drug sensitivity assays: current research and future trends.

Authors:  Emmanuel Mouafo Tekwu; William Kofi Anyan; Daniel Boamah; Kofi Owusu Baffour-Awuah; Stephanie Keyetat Tekwu; Veronique Penlap Beng; Alexander Kwadwo Nyarko; Kwabena Mante Bosompem
Journal:  Biomark Res       Date:  2016-11-22

6.  Inhibition of Notch Signaling Attenuates Schistosomiasis Hepatic Fibrosis via Blocking Macrophage M2 Polarization.

Authors:  Shaoping Zheng; Peige Zhang; Yixiong Chen; Shaojiang Zheng; Liping Zheng; Zhihong Weng
Journal:  PLoS One       Date:  2016-11-22       Impact factor: 3.240

Review 7.  Towards interruption of schistosomiasis transmission in sub-Saharan Africa: developing an appropriate environmental surveillance framework to guide and to support 'end game' interventions.

Authors:  J Russell Stothard; Suzy J Campbell; Mike Y Osei-Atweneboana; Timothy Durant; Michelle C Stanton; Nana-Kwadwo Biritwum; David Rollinson; Dieudonné R Eloundou Ombede; Louis-Albert Tchuem-Tchuenté
Journal:  Infect Dis Poverty       Date:  2017-01-14       Impact factor: 4.520

Review 8.  Schistosomiasis Drug Discovery in the Era of Automation and Artificial Intelligence.

Authors:  José T Moreira-Filho; Arthur C Silva; Rafael F Dantas; Barbara F Gomes; Lauro R Souza Neto; Jose Brandao-Neto; Raymond J Owens; Nicholas Furnham; Bruno J Neves; Floriano P Silva-Junior; Carolina H Andrade
Journal:  Front Immunol       Date:  2021-05-31       Impact factor: 7.561

9.  Fluorescence/luminescence-based markers for the assessment of Schistosoma mansoni schistosomula drug assays.

Authors:  Gordana Panic; Dayana Flores; Katrin Ingram-Sieber; Jennifer Keiser
Journal:  Parasit Vectors       Date:  2015-12-08       Impact factor: 3.876

10.  Identification of Host Insulin Binding Sites on Schistosoma japonicum Insulin Receptors.

Authors:  Rachel J Stephenson; Istvan Toth; Jiening Liang; Amanjot Mangat; Donald P McManus; Hong You
Journal:  PLoS One       Date:  2016-07-21       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.